Tempus ECG-AF vs Stethee Pro 1
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary objective is to proactively identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months, leveraging existing 12-lead ECG recordings. This tool is ideal for integrating into routine screenings to support earlier identification and follow-up for at-risk individuals without pre-existing AF or specific cardiac devices.
View Tempus ECG-AF →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you need a portable, AI-enabled wireless digital stethoscope for real-time, enhanced cardiac and respiratory vital sign analysis and auscultation, especially in telemedicine or remote monitoring settings. This system is best suited for immediate diagnostic assessment, providing sophisticated sound amplification, real-time visualization of heart and lung sounds, and secure data sharing capabilities.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Stethee Pro 1 |
|---|---|---|
| Pricing | Contact vendor | $499 usd |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Cloud, Mobile |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Stethee Pro 1Stethee Pro 1, with its wireless digital stethoscope, mobile app, and real-time visualization, offers a more immediate and interactive user experience. While Tempus ECG-AF integrates into existing systems, Stethee Pro 1's device-centric approach with quick data capture and intuitive UI for direct patient interaction likely provides superior usability for clinicians at the point of care.
Clinical Value
Tempus ECG-AFTempus ECG-AF provides a unique predictive risk assessment for atrial fibrillation within 12 months, enabling earlier identification and proactive intervention for a serious condition. While Stethee Pro 1 offers real-time diagnostic enhancement for current cardiac and respiratory issues, Tempus ECG-AF's focus on future risk prediction for AF presents a distinct and highly valuable clinical application for preventative care.
Pricing & Value
Tempus ECG-AFTempus ECG-AF offers transparent CMS reimbursement with a Medicare rate of $128.90, providing clear financial value and incentive for adoption in the US healthcare system. While Stethee Pro 1 has a clear device cost, the lack of a specified subscription price for its web portal makes a full cost-benefit analysis difficult for ongoing use.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF is designed as a software solution integrated into healthcare facility systems, explicitly stating HIPAA compliance and a Business Associate Agreement (BAA). This direct integration and confirmed compliance make it highly suitable for large-scale enterprise deployments within hospital and clinic systems.
Innovation
Stethee Pro 1Stethee Pro 1 is marketed as 'The World's First AI-Enabled Wireless Stethoscope System,' integrating advanced sound amplification, proprietary digital filters, and automatic geo-location with environmental data tagging. This reinvention of a traditional diagnostic tool with AI and comprehensive data enrichment demonstrates a broader scope of innovation in device design and functionality.
Support & Docs
Stethee Pro 1M3DICINE's website for Stethee Pro 1 provides a dedicated 'Support' section with FAQs and user manuals, offering structured and readily accessible documentation. Tempus AI's support for ECG-AF appears to be primarily through direct contact (email/phone) and general customer service, without a similarly organized public documentation portal for the specific product.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Stethee Pro 1 |
|---|---|---|
| Name | Tempus ECG-AF | Stethee Pro 1 |
| Company | Tempus AI, Inc. | M3DICINE |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | FDA-cleared, AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine. |
| Key Functionality | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. | AI-enabled wireless digital stethoscope system; Captures cardiac and respiratory vital signs in 20 seconds; Measures systole, diastole, heart cycle durations, and respiration rate; Sophisticated sound amplification (up to 96x) and 5 proprietary digital filters; Real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram). |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Emergency Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Stethee Pro 1.